Cat. No. 4562
Alternative Name: SK&F 104864-A
Chemical Name: 10-[(Dimethylamino)methyl]-4-ethyl-
Biological ActivityDNA topoisomerase I inhibitor; induces rapid apoptotic death in human B-lineage acute lymphoblastic leukemia (ALL) cells. Improves survival in three mouse models of poor prognosis ALL; downregulates B-Myb and MycN expression in neuroblastoma cells. Water-soluble analog of Camptothecin (Cat. No. 1100). Orally bioavailable.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Data Sheet
Sottile et al (2012) A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma. Oncotarget. 3 535. PMID: 22619121.
Schellens et al (1996) Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor. Br.J.Cancer 73 1268. PMID: 8630291.
Uckun et al (1995) In vitro and in vivo activity of topotecan against human B-lineage acute lymphoblastic leukemia cells. Blood 85 2817. PMID: 7742543.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for Topotecan hydrochloride include:
Pearson et al (2016) Identification of chemicals that mimic transcriptional changes associated with autism, brain aging and neurodegeneration. Int J Mol Med 7 11173. PMID: 27029645.
Do you know of a great paper that uses Topotecan hydrochloride from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Topotecan hydrochloride, supplier, Topotecan, HCl, DNA, topoisomerase, inhibitors, chemotherapeutics, Mycn, B-myb, inhibits, supplier, antineoplastics, orally, available, Tocris Bioscience, DNA Topoisomerase Inhibitor products